Back to search results

A Study of Roginolisib in Combination With Ruxolitinib in Patients With Myelofibrosis (MF) Who Are Unresponsive to JAK Inhibitors

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Myelofibrosis (MF)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Azienda Ospedaliero Universitaria Careggi Firenze, Struttura Complessa di Ematologia, Florence, Florence, Italy

    Contact: Study coordinator (Alessandro Vannucchi, Prof) · a.vannucchi@unifi.it · 0557947824 or : 0557947276
    Contact: Principal Investigator (Alessandro Vannucchi, Prof)

  • IRCCS Clinical Institute Humanitas, Rozzano, Milan, Italy

    Contact: Study coordinator (Armando Santoro, Prof) · armando.santoro@cancercenter.humanitas.it · +39 0282244080
    Contact: Principal Investigator (Armando Santoro, Prof)

  • Istituto di Ematolgia e Oncologia Medica, Bologna, Italy

    Contact: Study coordinator (Francesca Palandri, Prof) · francesca.palandri@unibo.it · +39512143044
    Contact: Principal Investigator (Francesca Palandri, Prof)

  • Istituto Romagnolo per lo Studio dei Tumori, Meldola, Italy

    Contact: Study coordinator (Alessandro Lucchesi, MD) · alessandro.lucchesi@irst.emr.it · 0039.0543.739292
    Contact: Principal Investigator (Alessandro Lucchesi)

  • Azienda Sanitario Universitaria Friuli Centrale, Udine, Italy

    Contact: Study coordinator (Mario Tiribelli, MD) · mario.tiribelli@uniud.it · +390342559662
    Contact: Principal Investigator (Mario Tiribelli, MD)

  • Vall d'Hebron University Hospital, Barcelona, Spain

    Contact: Study coordinator (Maria Laura Fox, MD) · mlfox@vhio.net · +34932746000
    Contact: Principal Investigator (Maria Laura Fox, MD)

  • Avigunda Gran via de l'Hospitalet 199-203, 08908 L'Hospitalet de Llobregat, Barcelona, Spain

    Contact: Study coordinator (Jasson Andrés Villareal Hernández, Dr) · jvillarreal@iconcologia.net · +34 93 260 70 68
    Contact: Principal Investigator (Jasson Andrés Villareal Hernández, Dr)

  • START Madrid CIOCC, Madrid, Spain

    Contact: Study coordinator (Damian Cubillas, MD) · damian.cubillas@startmadrid.com

  • Hospital Universitario de Salamanca, Salamanca, Spain

    Contact: Study coordinator (Jesus Maria Hernandez Riva, MD) · jmhr@usal.es · +34 9232911000
    Contact: Principal Investigator (Jesus Maria Hernandez Rivas, MD)

  • United Lincolnshire Teach Hospitals NHS Trust, Pilgrim Hospital Boston, Boston, Lincolnshire, United Kingdom

    Contact: Study coordinator (Ciro Rinaldi, Prof) · crinaldi@nhs.net

  • Belfast City Hospital, Belfast, United Kingdom

    Contact: Study coordinator (Graeme Greenfield, MD) · Graeme.Greenfield@belfasttrust.hscni.net

  • Guy´s and St. Thomas NHS Foundation Trust, London, United Kingdom

    Contact: Study coordinator (Priya Sriskandarajah) · priya.sriskandarajah@nhs.net · MD
Study leads

  • Michael Lahn, Dr

    Study Director

    iOnctura

View source on ClinicalTrials.gov(opens in a new tab)